Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.

Abstract:

BACKGROUND:Although adjuvant chemotherapy with S-1 after curative gastrectomy has been performed as a standard treatment for Stage II and III gastric cancer (GC) in Japan, patients with Stage III GC still have a high incidence of recurrence and a poor prognostic outcome. The aim of this study was to investigate risk factors for recurrence in patients with Stage III GC despite of curative gastrectomy followed by adjuvant chemotherapy, suggesting an indicator for more intensive management. METHODS:A total of 97 patients with pathological Stage III GC underwent adjuvant chemotherapy after curative gastrectomy between 2001 and 2014, were enrolled in this study. We retrospectively analyzed their hospital records from our hospital. RESULTS:The 5-year relapse-free survival (RFS) rates of patients with pStage III GC were 42.0%. Univariate and multivariate analyses for RFS revealed that venous invasion (v+) was an independent factor predicting a shorter RFS (v + vs. v-, 36.5% vs. 47.4%, P = 0.034, HR 1.82, 95% CI: 1.01-3.37). Venous invasion also predicted a shorter overall survival (OS) (v + vs. v-, 33.7% vs. 50.4%, P = 0.027). Regarding the patterns of recurrence, hematogenous recurrence was significantly occurred in patients with v + GC than those without (P = 0.022). CONCLUSIONS:Stage III GC with venous invasion is a high-risk subgroup for hematogenous recurrence after curative surgery followed by adjuvant chemotherapy. More intensive and effective adjuvant chemo and/or molecular targeted therapy for Stage III GC patients with venous invasion should be considered to improve their outcomes.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Nishibeppu K,Komatsu S,Ichikawa D,Imamura T,Kosuga T,Okamoto K,Konishi H,Shiozaki A,Fujiwara H,Otsuji E

doi

10.1186/s12885-018-4052-z

subject

Has Abstract

pub_date

2018-01-30 00:00:00

pages

108

issue

1

issn

1471-2407

pii

10.1186/s12885-018-4052-z

journal_volume

18

pub_type

杂志文章
  • The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.

    abstract:BACKGROUND:HIV infection is associated with a higher incidence of precancerous cervical lesions and their progression to invasive cervical cancer (ICC). Zambia is a global epicenter of HIV and ICC, yet the overall burden of cervical pre-cancer [cervical intraepithelial neoplasia 3 (CIN3)] and ICC among its HIV positive...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1558-5

    authors: Bateman AC,Katundu K,Mwanahamuntu MH,Kapambwe S,Sahasrabuddhe VV,Hicks ML,Chi BH,Stringer JS,Parham GP,Chibwesha CJ

    更新日期:2015-07-24 00:00:00

  • A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy.

    abstract:BACKGROUND:Art therapy may improve the physical, mental, and emotional wellbeing of individuals for a variety of purposes. It remains understudied and underutilized in cancer care. We sought to determine the ability of a pilot art therapy program to improve the physical, mental, and emotional well-being of cancer patie...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07380-5

    authors: Elimimian EB,Elson L,Stone E,Butler RS,Doll M,Roshon S,Kondaki C,Padgett A,Nahleh ZA

    更新日期:2020-09-22 00:00:00

  • Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.

    abstract:BACKGROUND:To date, the clinical benefit of topical steroid use has only been demonstrated for radiation dermatitis induced by 50-60 Gy irradiation in breast cancer. However, these agents are also often used clinically for the control of radiation dermatitis induced by high-dose (>60Gy) irradiation with chemotherapy in...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4763-1

    authors: Zenda S,Yamaguchi T,Yokota T,Miyaji T,Mashiko T,Tanaka M,Yonemura M,Takeno M,Okano T,Kawasaki T,Nakamori Y,Ishii S,Shimada S,Kanamaru M,Uchitomi Y

    更新日期:2018-09-06 00:00:00

  • Twist expression promotes migration and invasion in hepatocellular carcinoma.

    abstract:BACKGROUND:Twist, a transcription factor of the basic helix-loop-helix class, is reported to regulate cancer metastasis. It is known to induce epithelial-mesenchymal transition (EMT). In this study, we evaluated the expression of twist and its effect on cell migration in hepatocellular carcinoma (HCC). METHODS:We exam...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-240

    authors: Matsuo N,Shiraha H,Fujikawa T,Takaoka N,Ueda N,Tanaka S,Nishina S,Nakanishi Y,Uemura M,Takaki A,Nakamura S,Kobayashi Y,Nouso K,Yagi T,Yamamoto K

    更新日期:2009-07-18 00:00:00

  • Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.

    abstract:BACKGROUND:Lung adenocarcinoma (LUAD) is one of the most common cancer types, threatening the human health around the world. However, the high heterogeneity and complexity of LUAD limit the benefits of targeted therapies. This study aimed to identify the key prognosis impacting genes and relevant subtypes for LUAD. ME...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6462-y

    authors: Lv Z,Lei T

    更新日期:2020-01-27 00:00:00

  • Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.

    abstract:BACKGROUND:Non-muscle invasive bladder cancer (NMIBC) is usually treated with local therapy including transurethral resection of the bladder tumor and intravesical therapy depending on the stage of the tumor. NMIBC is a rarely a metastatic diseases with lymph node invasion in less of 10%. In the other hand meningeal ca...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3309-2

    authors: Teyssonneau D,Daste A,Dousset V,Hoepffner JL,Ravaud A,Gross-Goupil M

    更新日期:2017-05-11 00:00:00

  • Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia.

    abstract:BACKGROUND:We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS:NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up to the end of 2004. Ri...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-231

    authors: Yu XQ,Chen WH,O'Connell DL

    更新日期:2010-05-24 00:00:00

  • Distinct molecular subtypes of uterine leiomyosarcoma respond differently to chemotherapy treatment.

    abstract:BACKGROUND:Uterine leiomyosarcoma (ULMS) is an aggressive form of soft tissue tumors. The molecular heterogeneity and pathogenesis of ULMS are not well understood. METHODS:Expression profiling data were used to determine the possibility and optimal number of ULMS molecular subtypes. Next, clinicopathological character...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3568-y

    authors: An Y,Wang S,Li S,Zhang L,Wang D,Wang H,Zhu S,Zhu W,Li Y,Chen W,Ji S,Guo X

    更新日期:2017-09-11 00:00:00

  • The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells.

    abstract:BACKGROUND:Cationic antimicrobial peptides (CAPs) with antitumor activity constitute a promising group of novel anticancer agents. These peptides induce lysis of cancer cells through interactions with the plasma membrane. It is not known which cancer cell membrane components influence their susceptibility to CAPs. We h...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-183

    authors: Fadnes B,Rekdal O,Uhlin-Hansen L

    更新日期:2009-06-15 00:00:00

  • Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.

    abstract:BACKGROUND:To characterize prognostic and risk factors of central nervous system (CNS) metastases in patients with epithelial ovarian cancer (EOC). METHODS:A retrospective analysis of Xijing Hospital electronic medical records was conducted to identify patients with pathologically confirmed EOC and CNS metastases. In ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-829

    authors: Liu BL,Liu SJ,Baskys A,Cheng H,Han Y,Xie C,Song H,Li J,Xin XY

    更新日期:2014-11-17 00:00:00

  • Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.

    abstract:BACKGROUND:Nasopharyngeal carcinoma (NPC) is a type of head-neck cancer with a distinguishable geographic and racial distribution worldwide. Increasing evidence supports that the accumulation of additional genetic and epigenetic abnormalities is important in driving the NPC tumorigenic process. In this study, we aim to...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2714-2

    authors: Huang PY,Zeng TT,Ban X,Li MQ,Zhang BZ,Zhu YH,Hua WF,Mai HQ,Zhang L,Guan XY,Li Y

    更新日期:2016-08-22 00:00:00

  • Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.

    abstract:BACKGROUND:The centralisation of specialist cancer surgical services across London Cancer and Greater Manchester Cancer, England, may significantly change how patients experience care. These centres are changing specialist surgical pathways for several cancers including prostate, bladder, kidney, and oesophago-gastric ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4137-8

    authors: Melnychuk M,Vindrola-Padros C,Aitchison M,Clarke CS,Fulop NJ,Levermore C,Maddineni SB,Moore CM,Mughal MM,Perry C,Pritchard-Jones K,Ramsay AIG,Shackley D,Vickers J,Morris S

    更新日期:2018-02-27 00:00:00

  • Household inhalants exposure and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China.

    abstract:BACKGROUND:Epidemiological studies show that cigarette smoking increase the risk of nasopharyngeal carcinoma (NPC), however, whether other common, potentially adverse household inhalants increase NPC risk remains uncertain. METHODS:We conducted a large case-control study to explore the effects of household inhalants, ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-2035-x

    authors: He YQ,Xue WQ,Shen GP,Tang LL,Zeng YX,Jia WH

    更新日期:2015-12-29 00:00:00

  • The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.

    abstract:BACKGROUND:The association of genes XRCC1, TP53 and MDM2 with breast cancer (BC) has never been tested in Kyrgyz population. We, therefore, aimed to identify an association of alleles and genotypes of polymorphic markers Arg399Gln of gene XRCC1, Arg72Pro of gene TP53, and T309G of gene MDM2 with the risk of BC in Kyrgy...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3762-y

    authors: Isakova J,Talaibekova E,Aldasheva N,Vinnikov D,Aldashev A

    更新日期:2017-11-13 00:00:00

  • The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation.

    abstract:BACKGROUND:Limited studies examine the immune landscape in Esophageal Adenocarcinoma (EAC). We aim to identify novel associations, which may inform immunotherapy treatment stratification. METHODS:Three hundred twenty-nine EAC cases were available in Tissue Microarrays (TMA) format. A discovery cohort of 166 EAC cases ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06987-y

    authors: Humphries MP,Craig SG,Kacprzyk R,Fisher NC,Bingham V,McQuaid S,Murray GI,McManus D,Turkington RC,James J,Salto-Tellez M

    更新日期:2020-06-01 00:00:00

  • Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.

    abstract:BACKGROUND:TGFβ signaling has typically been associated with suppression of tumor initiation while the role it plays in metastasis is generally associated with progression of malignancy. However, we present evidence here for an anti-metastatic role of TGFβ signaling. METHODS:To test the importance of TGFβ signaling to...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-221

    authors: Simms NA,Rajput A,Sharratt EA,Ongchin M,Teggart CA,Wang J,Brattain MG

    更新日期:2012-06-06 00:00:00

  • Lentivirus-mediated CDglyTK gene-modified free flaps by intra-artery perfusion show targeted therapeutic efficacy in rat model of breast cancer.

    abstract:BACKGROUND:Free flap-mediated gene therapy in the tumor bed following surgical resection is a promising approach in cancer targeted treatment of residual disease. We investigated the selective killing efficacy of a lentivirus-mediated cytosine deaminase-thymidine kinase (CDglyTK) gene in transplanted breast cancer deli...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6111-5

    authors: Zhang J,Liu Y,Zang M,Zhu S,Chen B,Li S,Xue B,Yan L

    更新日期:2019-09-14 00:00:00

  • Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.

    abstract:BACKGROUND:PRDM5 is an epigenetic regulator that has been recognized as an important tumour suppressor gene. Silencing of PRDM5 by promoter hypermethylation has been demonstrated in several cancer types and PRDM5 loss results in upregulation of the Wnt pathway and increased cellular proliferation. PRDM5 has not been ex...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1011-9

    authors: Bond CE,Bettington ML,Pearson SA,McKeone DM,Leggett BA,Whitehall VL

    更新日期:2015-01-23 00:00:00

  • Li-Fraumeni syndrome with simultaneous osteosarcoma and liver cancer: increased expression of a CD44 variant isoform after chemotherapy.

    abstract:BACKGROUND:Li-Fraumeni syndrome (LFS) is a hereditary cancer predisposition syndrome that is commonly associated with a germline mutation in the tumor suppressor gene p53. Loss of p53 results in increased expression of CD44, a cancer stem cell (CSC) marker, which is involved in the scavenging of reactive oxygen species...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-444

    authors: Yoshida GJ,Fuchimoto Y,Osumi T,Shimada H,Hosaka S,Morioka H,Mukai M,Masugi Y,Sakamoto M,Kuroda T

    更新日期:2012-10-02 00:00:00

  • Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.

    abstract:BACKGROUND:Platelets are frequently altered in hepatocellular carcinoma (HCC) patients. Platelet lysates (hPL) can enhance HCC cell growth and decrease apoptosis. The aims were to evaluate whether hPL can modulate the actions of sorafenib or regorafenib, two clinical HCC multikinase antagonists. METHODS:Several human ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-351

    authors: D'Alessandro R,Refolo MG,Lippolis C,Giannuzzi G,Carella N,Messa C,Cavallini A,Carr BI

    更新日期:2014-05-21 00:00:00

  • The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ.

    abstract:BACKGROUND:Tyrosine kinase inhibitors (TKIs) have become the mainstay of treatment for advanced renal cell carcinoma (RCC), but it has been unclear whether the antitumor effect of TKIs depends on the organ where the RCC metastasis is located. We previously reported that the FDG accumulation assessed by FDG PET/CT, was ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-390

    authors: Kakizoe M,Yao M,Tateishi U,Minamimoto R,Ueno D,Namura K,Makiyama K,Hayashi N,Sano F,Kishida T,Kobayashi K,Noguchi S,Ikeda I,Ohgo Y,Taguri M,Morita S,Inoue T,Kubota Y,Nakaigawa N

    更新日期:2014-06-02 00:00:00

  • Smokers' interest in a lung cancer screening programme: a national survey in England.

    abstract:BACKGROUND:Following the recommendation of lung cancer screening in the US, screening committees in several European countries are reviewing the evidence for implementing national programmes. However, inadequate participation from high-risk groups poses a potential barrier to its effectiveness. The present study examin...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4430-6

    authors: Quaife SL,Vrinten C,Ruparel M,Janes SM,Beeken RJ,Waller J,McEwen A

    更新日期:2018-05-02 00:00:00

  • Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer.

    abstract:BACKGROUND:Hyaluronan (HA) an important component of the extracellular matrix, has been linked to tumor progression and drug resistance in several malignancies. However, limited data is available for ovarian cancer. This study investigated the role of hyaluronan (HA) and a potential link between the HA-CD44 pathway and...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-476

    authors: Ricciardelli C,Ween MP,Lokman NA,Tan IA,Pyragius CE,Oehler MK

    更新日期:2013-10-14 00:00:00

  • Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies.

    abstract:BACKGROUND:The development of non-small cell lung carcinoma proceeds through a series of well-defined pathological steps before the appearance of invasive lung carcinoma. The molecular changes that correspond with pathology changes are not well defined and identification of the molecular events may provide clues on the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-155

    authors: Tichelaar JW,Zhang Y,leRiche JC,Biddinger PW,Lam S,Anderson MW

    更新日期:2005-12-06 00:00:00

  • Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.

    abstract:BACKGROUND:Thyroid cancer is among the fastest growing malignancies; almost fifty-percent of these rapidly increasing incidence tumors are less than or equal to 1cm in size, termed papillary thyroid microcarcinoma (PTMC). The management of PTMC remains a controversy due to differing natural history of these patients. E...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-523

    authors: Kunavisarut T,Kak I,Macmillan C,Ralhan R,Walfish PG

    更新日期:2012-11-15 00:00:00

  • Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016.

    abstract:BACKGROUND:Cancer patient pathways (CPPs) were implemented in 2015 to reduce waiting time, regional variation in waiting time, and to increase the predictability of cancer care for the patients. The aims of this study were to see if the national target of 70% of all cancer patients being included in a CPP was met, and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06979-y

    authors: Nilssen Y,Brustugun OT,Eriksen MT,Haug ES,Naume B,Møller B

    更新日期:2020-05-30 00:00:00

  • Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.

    abstract:BACKGROUND:Matrix metalloproteinases (MMPs) are crucially involved in the regulation of multiple stages of cancer progression. Elevated MMP levels have been associated with the development of metastases and poor prognosis in several types of cancer. However, the role of MMPs in osteosarcoma and their prognostic value i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2266-5

    authors: Kunz P,Sähr H,Lehner B,Fischer C,Seebach E,Fellenberg J

    更新日期:2016-03-15 00:00:00

  • Extramammary Paget's disease with the appearance of a nodule: a case report.

    abstract:BACKGROUND:Extramammary Paget's disease (EMPD) remains a rare condition with only a limited number of cases reported in the literature. EMPD is mainly composed of intraepidermal Paget cells, and possesses variable clinical behaviors and histological appearances, leading to difficulty in the diagnosis of this disease. ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-405

    authors: Wang X,Yang W,Yang J

    更新日期:2010-08-04 00:00:00

  • Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1.

    abstract:BACKGROUND:Cancer of unknown primary remains a mallignancy of elusive biology and grim prognosis that lacks effective therapeutic options. We investigated angiogenesis in cancer of unknown primary to expand our knowledge on the biology of these tumors and identify potential therapeutic targets. METHODS:Paraffin embedd...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-25

    authors: Karavasilis V,Malamou-Mitsi V,Briasoulis E,Tsanou E,Kitsou E,Kalofonos H,Fountzilas G,Fotsis T,Pavlidis N

    更新日期:2005-03-03 00:00:00

  • The effect of metformin and thiazolidinedione use on lung cancer in diabetics.

    abstract:BACKGROUND:Metformin and the thiazolidinediones (TZDs) may have a protective effect against the development of lung cancer. METHODS:Patients with diabetes mellitus (DM) were identified from the electronic medical records of the Cleveland Clinic. Diabetics with lung cancer were identified then verified by direct review...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-410

    authors: Mazzone PJ,Rai H,Beukemann M,Xu M,Jain A,Sasidhar M

    更新日期:2012-09-14 00:00:00